Fox Chase Cancer Center News

Fox Chase Cancer Center Researcher Helps Finds Key Resistance Mechanism in Breast Cancer That Could Lead to More Effective Treatment

Targeted cancer drugs known as CDK4/6 inhibitors have improved outcomes for patients with advanced or metastatic HR+/HER2- breast cancer, but many patients still eventually relapse and become resistant to therapy. New research co-headed by a Fox Chase Cancer Center scientist helps explain why — and offers three strategies for making treatment more effective.

VIEW STORY